Invention Grant
- Patent Title: Use of C-type natriuretic peptide variants to treat skeletal dysplasia
-
Application No.: US15225355Application Date: 2016-08-01
-
Publication No.: US09907834B2Publication Date: 2018-03-06
- Inventor: Sherry Bullens , Stuart Bunting , Tianwei Chou , Augustus O. Okhamafe , Christopher P. Price , Daniel J. Wendt , Clarence Yap
- Applicant: BIOMARIN PHARMACEUTICAL INC.
- Applicant Address: US CA Novato
- Assignee: BioMarin Pharmaceutical Inc.
- Current Assignee: BioMarin Pharmaceutical Inc.
- Current Assignee Address: US CA Novato
- Agency: Greenberg Traurig, LLP
- Agent Melissa Hunter-Ensor; Leslie Serunian
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/22 ; A61K9/19 ; A61K47/12 ; A61K47/26 ; A61K47/18 ; A61K47/10 ; A61K9/00 ; A61K38/17
Abstract:
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
Public/Granted literature
- US20170028023A1 USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA Public/Granted day:2017-02-02
Information query
IPC分类:
